In order to clarify whether the ovarian tumors induced in a long-term carcinogenicity study of nitrofurazone (NF) in mice can be also produced in a short-term model using transgenic (Tg) mice carrying the human c-Ha-ras gene (rasH2 mice), the following 3 experiments were performed. In experiment 1, both rasH2 mice and their wild CB6F 1 littermates carrying no c-Ha-ras gene (non-Tg mice) that were fed a diet containing 500 to 1,000 ppm NF for 7 weeks demonstrated ovarian atrophy characterized by decreased labeling indices (LIs) for proliferating cell nuclear antigen (PCNA) in granulosa cells. In experiment 2, increased numbers of atretic follicles and decreased PCNA LIs in granulosa cells were recognized in rasH2 mice given diets containing 250 or 500 ppm NF for 26 weeks, but no tumor induction was grossly observed. In experiment 3, similar ovarian atrophy was observed in association with increased serum luteinizing hormone (LH) levels in both rasH2 and non-Tg mice given diet containing 1,000 ppm NF for 11 days. These results indicate that long-term NF treatment induces ovarian tumors in mice, possibly by continuous stimulation with gonadotropins such as LH via a negative-feedback phenomenon secondary to ovarian atrophy (as the tumor-induction mechanism), although we could not completely rule out a genotoxic mechanism.
INTRODUCTION
Nitrofurazone (NF) is a broad-spectrum antimicrobial drug used both therapeutically and prophylactically in a number of food-producing species including pigs, sheep, goats, cattle, chickens, and turkeys. Two-year dietary carcinogenicity bioassays of NF using rodents revealed induction of ovarian tumors in mice and of mammary tumors in rats (15) . Ovarian granulosa cell tumors and benign mixed ovarian tumors were observed, along with increased incidences of ovarian atrophy and tubular cell hyperplasia, in mice given NF at daily oral doses of 14 and 28 mg/kg body weight (bw)/d. Increased incidences of mammary tumors were found in female rats given 11 I and 24 mg/kg bw/d. Because NF has been reported to be positive in in vitro mutagenicity studies (although negative in some in vivo tests; 15), a genotoxic mechanism might be involved. However, NF is known to cause persistent estrus and to block 11-hydroxylation, which is responsible for conversion of deoxycorticosterone to corticosterone, when given to rats for 325 days (23) . Therefore, a change in the endocrine balance must also be considered as a mechanism of tumor induction. The Food and Agriculture Organization/World Health Organization Joint Expert Committee on Food Additives (JECFA) reviewed data on NF in 1992 and concluded that an &dquo;Acceptable Daily Intake&dquo; for NF could not be established, because no-effect levels had not been determined in 2- year carcinogenicity bioassays in rats and mice and be-cause the carcinogenic mechanism remained to be elucidated (23) .
It has recently been reported that transgenic (Tg) CB6F, mice carrying the human prototype c-Ha-ras gene (rasH2 mice) are much more susceptible to various carcinogens than are non-Tg mice, thus providing a promising short-term animal model for the detection of the carcinogenic potential of pharmaceutical drugs (11, 12, (19) (20) (21) (22) . The present studies were performed in order 1) to clarify whether the ovarian tumors induced in a long-term carcinogenicity study of NF in mice can also be produced in a short-term study using rasH2 mice and 2) to examine toxic effects of high doses of NF (for a short duration) on the genital and endocrine organs. METHODS Experiment 1. The F1 offspring of C57BL/6J male mice carrying the prototype human c-Ha-ras gene crossed with BALB/cByJ female mice were screened by polymerase chain reaction or Southern blot analysis for the presence of the transgene and were divided into 2 groups. At 6 weeks of age, 14 female rasH2 mice and 14 female non-Tg CB6Ft littermates were received from the Central Institute for Experimental Animals (Kanagawa, Japan) and were separately allocated (following a 2-week acclimatization period) to NF-treated and -untreated groups consisting of 9 and 5 mice, respectively. Animals were housed in plastic cages (4 to 5 animals per cage, with wood chips as bedding) in an air-conditioned animal room (temperature, 23 ± 2°C; relative humidity, 55 ± 5%; lighting cycle, 12-hour light-dark). Pulverized diet (MF, Oriental Yeast Co, Ltd, Tokyo, Japan) and distilled drinking water were available ad libitum. The NF-treated groups were given the compound (Sigma Chemical Co, St. Louis, MO) in the diet at 1,000 ppm for the first 2 weeks. This high dose was chosen so that we could observe the early toxic effects of administration of the maximum tolerated dose for a short period, based on the fact that mice died at the dietary concentration of 1,250 ppm or more during a 14-day study (15) . Treatment was then withdrawn for 2 weeks (because of mortality); following this 2-week treatment cessation, we returned the animals to a diet containing 500 ppm NF from weeks 5 to 7. Untreated mice were fed the NF-free diet throughout the course of the experiment. At the end of week 7, survivors were necropsied following exsanguination under ether anesthesia, and reproductive organs were routinely processed for histopathological examination of hematoxylin and eosin (HE)-stained sections. The cell proliferative activity of granulosa cells in the ovarian follicles was examined by immunohistochemistry using antibody to proliferating cell nuclear antigen (PCNA). Primary mouse monoclonal and secondary biotinylated rabbit antibodies were purchased from DAKO (Glostrup, Denmark), and the avidin-biotin-peroxidase complex method was performed using 3,3'-diaminobenzidine (Wako Pure Chemical, Osaka, Japan) as the chromogen. PCNA labeling indices (LIs) were calculated for all granulosa cells in 2 follicles in each animal. For examination of the vagina, PCNA immunohistochemistry and the TUNEL method for detection of apoptosis were performed. PCNA LIs and rates of TUNEL-positive cells were calculated for 1.5-mm lengths of epithelium. The same immunohistochemical method described above was applied for PCNA, and POD (in situ Cell Death Detection Kit, Boehringer Mannheim GmbH, Mannheim, Germany) was used for TUNEL. Differences in PCNA and TUNEL LIs between the NF-treated and -untreated groups were examined for statistical significance with the Student's ttest. Experiment 2. Thirty-three female rasH2 mice (9-week old) were used after a 1-week acclimatization (with housing as described in experiment 1). They were given NF in the diet at concentrations of 0, 250, and 500 ppm for TABLE l.-Histopathological findings for the reproductive system of female rasH2 and non-Tg mice given nitrofurazone (NF) for 7 weeks (experiment 1). a The vaginal estrus cycles could not be classified for 2 animals. 1 to 5 layers. In addition, serum levels of estradiol-17P (E2) and progesterone (P) were measured using Estradiol and Progesterone Kits (Nippon DPC Corp, Chiba, Japan).
Differences in numerical data between the NF-treated and -untreated groups were examined for statistical significance using the Student's t-test. Experiment 3. Eight-week-old female rasH2 mice and non-Tg mice were allocated to 2 groups (consisting of 5 mice each) after a 2-week acclimatization period and were housed under the same conditions described in experiment 1. Mice were given NF (via their diet) at concentrations of 0 and 1,000 ppm for 11 days, and mice were necropsied after exsanguination under ether anesthesia. The ovaries were removed and processed for examination of sections that were either stained with HE or immunohistochemically reacted for PCNA. The numbers of follicles of each stage were counted in the same manner as described in experiment 2, and PCNA LIs were measured for granulosa cells in follicles at all stages with 1 to 4 layers. In addition, serum levels of luteinizing hormone (LH) and prolactin were respectively measured using a rat luteinizing hormone (rLH) [l2sl] assay system (Amersham International plc, Buckinghamshire, UK) and an enzyme-linked immunosorbent assay method developed by Panapharm Laboratories (Kumamoto, Japan).
Differences in numerical data between the NF-treated and -untreated groups were examined for statistical significance using the Student's t-test.
RESULTS

Experiment 1
Four rasH2 mice and 6 non-Tg mice, all of which were treated with NF, were euthanatized in a moribund condition. Body weights of the NF-treated groups were decreased during the first 2 weeks, but after the NF withdrawal, these weights recovered to the levels associated with untreated mice and were not affected after resumption of treatment. NF caused ovarian and uterine atrophy in both rasH2 and non-Tg mice. Six of seven rasH2 mice treated with NF demonstrated a proestrus or estrus appearance of vaginal epithelia, except for 2 animals, whose cycles could not be classified (Table 1 ). PCNA LIs of follicular granulosa cells were significantly decreased in the NF-treated mice compared with the corresponding control values (Table 2 ). In the vaginal epithelium, PCNA -PCNA labeling indices (LIs) of granulosa cells in ovarian follicles and PCNA LIs and the rates of TUNEL-positive cells in the vaginal epithelia of rasH2 and non-Tg mice given 500 to 1,000 ppm nitrofurazone (NF) in the diet for 7 weeks (experiment 1).° Mean ± standard deviation. *, ** Significantly different from the untreated group value at p < 0.05 and 0.01, respectively.
LIs and TUNEL-positive cells were significantly decreased and increased, respectively, by NF treatment in non-Tg mice. Only the change in PCNA LI was significant in rasH2 mice ( Table 2 ). No differences between rasH2 and non-Tg mice were observed.
Experiment 2
The number of smaller follicles was increased in the 500 ppm group compared with values in the untreated group, although those with 2 layers were not statistically significant. When the numbers of follicles with 1 to 3 layers were pooled, this value was also significantly increased in the 500 ppm group compared with the 0 ppm group. Concomitantly, Graafian follicles revealed a significant decrease in the NF-treated groups. Atretic follicles were significantly increased in the 500 ppm group (Figures 1-5 ). PCNA LIs ,of follicles with 2 to 5 layers of granulosa cells were clearly lower in the NF-treated than in the NF-untreated groups (Figure 6 ). No proliferative lesions, such as neoplasias or hyperplasias, were observed in the ovaries as a result of the histological examination. Measurement of serum hormone levels revealed no significant treatment-related changes in either E2 or P levels, although the latter tended to be increased (Table 3) . 
Experiment 3
Atretic follicles were also significantly increased by the 11-day treatment with 1,000 ppm NF in both rasH2 and non-Tg mice compared to the number of follicles in the untreated groups, as was the case in experiment 2. The numbers of smaller follicles consisting of 1 to 3 layers also tended to be increased by the treatment, although this increase was without significance (Figure 7 ). On the other hand, the numbers of corpora lutea were signifi-FIGURE 2.-Ovary of an untreated rasH2 mouse (experiment 2). Follicles of various stages, from primordial to larger follicles, are evident.
HE. X 50. cantly decreased by NF in rasH2 mice but not in the treated non-Tg mice (Figure 7 ). No significant variation in PCNA LIs of granulosa cells was observed between 1,000 and 0 ppm groups of rasH2 and non-Tg mice (Figure 8) . The serum level of luteinizing hormone was significantly increased in the NF-treated compared to the control non-Tg mice, and the level also tended to be elevated in the treated rasH2 mice. Prolactin levels were generally lower in the NF-treated groups than in the untreated groups, but this difference was not statistically significant (Table 4 ).
DISCUSSION
The National Toxicology Program has conducted carcinogenicity studies of NF in rats and mice (15) . Although NF proved tumorigenic in these studies, the lesions produced were benign and were restricted to the mammary gland and endocrine organs such as the ovaries. In the majority of in vitro mutagenicity studies of forward mutations in bacteria, yeast, and mammalian cells, positive results were obtained (4, 8, 15) . Positive results were also noted in tests for DNA damage in bacteria and in mammalian cells, in tests for clastogenic ef- (8, 15, 16, 18) . However, in vivo tests of clastogenic potential in Chinese hamster or rat bone-marrow cells were negative (3, 9) . In addition, it has been demonstrated that nitrofurans, including NF, block 11-hydroxylation of deoxycorticosterone to corticosterone and induce persistent estrus when given to rats j for 325 days (this indicates a fluctuation of the endocrine balance) (23) . Based on these data, the JECFA considers NF to be an indirect-acting carcinogen that produces its :JI effects in endocrine-responsive organs via a nongenotoxic mechanism (23).
The present series of studies revealed similar atrophic changes of the ovary in both rasH2 and non-Tg NF-treated mice. Moreover, increase of small or atretic follicles and decrease of larger follicles indicated inhibition of follicular growth. This was supported by decreased PCNA LIs of granulosa cells. The dose of 1,000 ppm, administered at the early stage of experiment 1 and throughout the treatment period of experiment 3, was considered to be toxic, since treated animals showed decreased body weights. Therefore, we must take into account the possibility that NF possibly caused the ovarian atrophy via Figure 4 at higher magnification, demonstrating many atretic (arrows) and small follicles with I or 2 layers of granulosa cells without oocytes (arrowheads). X 120. the mechanism of undemutrition. However, body weights were recovered when we reduced the dose to 500 ppm in the latter half of the treatment period in experiment 1, and doses of 250 and 500 ppm, which were not severely toxic, also caused ovarian atrophy in experiment 2. Accordingly, the cause of the atrophy is not considered to be undernutrition, but rather, the cause is considered to be some fluctuation of ovarian function that resulted from the NF treatment. The ovarian atrophy presumably caused decreased estrogen secretion from the ovary, decreased secretion that was in line with the lowered PCNA LIs and increased TUNEL-positive cells in the vaginal epithelia. On the other hand, the fact that the proestrus or estrus appearance of the vagina was slightly enhanced in NF-treated rasH2 mice in experiment 1 might indicate increased serum estrogen levels. However, these changes are considered to be secondary to atrophy of the ovary, because such atrophy has, in fact, been shown to cause relatively high serum estrogen (compared with progesterone) levels and vaginal epithelial changes that are indicative of persistent estrus in a case involving rats (14) . The reason for the discrepancy (ie, serum E2 levels were FIGURE 6.-PCNA labeling indices (LIs) of granulosa cells in ovarian follicles at each stage in rasH2 mice given nitrofurazone in the diet for 26 weeks (experiment 2). 1, 2, 3, and 5, follicles consist of 1, 2, 3, and 5 layers of granulosa cells, respectively. Columns and bars represent means and standard deviations. a) Standard deviations could not be calculated, because single follicles consisting of 3 or 5 layers of granulosa cells were only observed in 1 case. b) No follicles consisting of 5 layers of granulosa cells were seen. Single (*) and double (**) asterisks indicate values that are significantly different from the untreated group at p < 0.05 and 0.01, respectively. not decreased in spite of ovarian atrophy after treatment with NF for 26 weeks) in experiment 2 was not clear. However, since estrogens are also produced by organs other than the ovary, such estrogen production by the other organs is considered to mask the fluctuation of the systemic estrogen level.
The increase of serum LH observed in experiment 3 indicated that gonadotropin release from the pituitary might have been elevated, although the levels of folliclestimulating hormone were not examined. It is well known that granulosa cell tumors are induced by the increased levels of circulating gonadotropins that are responding to ovarian atrophy (1) . The benign mixed ovarian tumors that were also induced by NF in a 2-year bioassay are believed to originate from ovarian epithelial cells with stromal components (1, 2, 7, 17) and are also referred to as tubular adenomas. It has been reported that this type of tumor can be caused by prolonged gonadotropin stimulation, as is the case with granulosa cell tumors (13) . Moreover, these tumors can also be induced by interference in ovarian development (10) . Since the 1,000 ppm NF dose to which mice were exposed in experiment 3 was extremely toxic, as described above, the increase of LH levels possibly resulted from the severe toxic con- Follicle-stimulating hormone and LH release from the pituitary could be secondarily induced via a negativefeedback response to decreased estrogen secretion, according to atretic changes of follicles. In addition, the possibility that NF can directly affect the hypothalamus or pituitary cannot be precluded, because the increase in LH level has been reported to cause decreased expression f of estrogen receptors in granulosa cells (5, 6) . However, it remains to be clarified which mechanisms were responsible for the findings in the present experiments. In experiment 2, no induction of ovarian tumors or preneoplastic lesions was observed in NF-treated rasH2 mice, and full necropsy revealed no tumor induction in any other organs of these mice (which have been reported to be useful for the detection of carcinogens within a 26week treatment period) (11, 12, (19) (20) (21) (22) . Therefore, the absence of proliferative lesions minimizes the possibility that NF has carcinogenic potentials in vivo. On the other hand, based on our results, the susceptibility of rasH2 mice to ovarian carcinogenesis was questionable. A longer treatment period, one that exceeds 26 weeks, may be necessary to clarify whether NF induces ovarian tumors in rasH2 mice. However, since ovarian tumors were restricted to mice that had been subjected to long-term treatment via secondary mechanisms, the carcinogenic risk for humans can be regarded to be very low. In conclusion, it can be speculated that a nongenotoxic mechanism involving elevated serum LH levels underlies the ovarian tumor induction by NF treatment in mice, although we could not completely rule out a genotoxic mechanism.
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